- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03116958
MyOSA : Management and Treatment of Patients With Obstructive Sleep Apnea Syndrome(OSAS) Through a Telemedicine System (MyOSA)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obstructive Sleep Apnea (OSA) is defined by the presence of repetitive episodes of upper airways collapse during sleep, leading to nocturnal hypoxemia, sleep fragmentation and daytime sleepiness. When untreated, OSA is a risk factor for arterial hypertension , cardiovascular and cerebrovascular diseases, road accidents and a worse quality of life. The application of a continuous positive airways pressure (CPAP) represents the first line therapy in patients with moderate to severe OSA. CPAP treatment improves daytime sleepiness and oxygen saturation, reduces cardiovascular risk, ameliorates neurobehavioral performance, improves quality of life and reduces road accidents. Despite its demonstrated efficacy, CPAP effectiveness is significantly limited by poor adherence. A closer follow up could improve CPAP adherence but it would take up more work and additional costs for sleep units.
So, on that account, the investigators propose a study to evaluate the effect of adding a telemedicine approach to traditional follow up on CPAP treatment compliance, patients' satisfaction and follow-up costs.
Telemedicine will be provided by an integrated platform composed by a web site (https://www.myosa.net/menu/login.aspx) and a smartphone application.
Methods:
Design: Prospective randomised clinical study. Follow up: 6 months. Participants: 60 patients diagnosed as OSA at St. Maria's Hospital (Sleep Unit) and requiring CPAP treatment.
Randomization: Patients will be randomized into two groups differing in CPAP treatment management (standard care vs. telemedicine). Patients of both groups will be visited in Sleep Unit at 3st and 6th month after starting CPAP treatment. The CPAP machine of both groups will be provided with a modem sending daily information about CPAP treatment compliance and adherence to MyOSA web site (this kind of information will only be actively used during the follow-up in the telemedicine group).
Intervention:
Group 1- Telemedicine Patients will be fitted with a mask , given a CPAP, and instructed on how to use the device. An intelligent software specifically developed for this project will be integrated in the web site. Using patients' baseline data (sociodemographic characteristics, presence of comorbidities, quality of life, sleepiness, pharmacologic treatment, toxic habits), the software will be capable to provide an initial prediction of the expected CPAP compliance at 6 months. Then, the real data about patients' treatment compliance sent on daily base by the CPAP machine will train the software improving the level of confidence of the prediction. Based on the prediction of compliance at six months, the software will provide specific and personalized interventions to modify or maintain this prediction. Interventions will be administered to the patients through a smartphone application connected to the web site and specifically developed for this study (MyOSA-App). Using the mobile-app patients will receive information about their own CPAP compliance and advice on how to improve compliance. All patients will be visited at 3 and 6 months at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine.
Group 2- Standard care Patients will be fitted with a mask and given a CPAP and instructed on how to use the device. Each CPAP machine will be provided with a modem sending daily compliance and adherence information to MyOSA web site but no intervention based on these data is planned in this group. All patients will be visited at 1, 3 and 6 months at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine. Information will be downloaded from their machines (CPAP adherence, applied CPAP pressure, mask leak, and residual respiratory events…).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lleida, Spain, 25198
- Hospital Arnau de Vilanova
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and Women over 18 years old
- Diagnosed as OSA and requiring CPAP treatment
- Good knowledge of the use of a smartphone
- Written informed consent form signed
Exclusion Criteria:
- Patients with impaired lung function (overlap syndrome, obesity hypoventilation syndrome, and restrictive disorders)
- Severe heart failure
- Severe chronic pathology associated
- Psychiatric disorder
- Periodic leg movements
- Pregnancy
- Other dyssomnias or parasomnias
- Patients already treated with CPAP
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Standard care
Patients diagnosed as OSA, treated with CPAP and followed up in sleep unit as per usual care. Patients will be fitted with a mask and given a CPAP and instructed on how to use the device. Each CPAP machine will be provided with a modem sending daily compliance and adherence information to MyOSA web site but no intervention based on these data is planned in this group. All patients will be visited at 1,3 and 6 months at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine. Information will be downloaded from their machines (CPAP adherence, applied CPAP pressure, mask leak, and residual respiratory events…). |
CPAP device + Standard management at Sleep Unit.
According to Spanish Respiratory Society guidelines during 6 months
|
EXPERIMENTAL: Telemedicine
Patients diagnosed as OSA and treated with CPAP, followed up in sleep unit, adding a telemedicine integrated system. Patients will be fitted with a mask , given a CPAP, and instructed on how to use the device. Using patients' baseline and initial follow-up data a software will provide a prediction of CPAP compliance at 6 months, and propose personalized interventions to increase compliance (smartphone app). All patients will be visited at 3 and 6 months at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine. |
CPAP+ telemedicine approach.
Patients followed up at Sleep Unit according to Spanish Respiratory Society guidelines during 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CPAP compliance
Time Frame: 6 months
|
Number of hours of use per day of CPAP according to the internal clock of the CPAP device
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CPAP adherence
Time Frame: 6 months
|
Numbers of night with more than 4 hours of use
|
6 months
|
Patients' perceived ease of use of the telemedicine system
Time Frame: 6 months
|
Patients in the telemedicine group will be asked to grade the perceived ease of use of the telemedicine platform using a questionnaire
|
6 months
|
Patients' perceived useful of the telemedicine system
Time Frame: 6 months
|
Patients in the telemedicine group will be asked to grade the perceived useful of the telemedicine platform using a questionnaire
|
6 months
|
Patients' follow-up satisfaction
Time Frame: 6 months
|
Patients of both group will be asked to grade their satisfaction with the follow up care provided by the sleep unit using a questionnaire.
|
6 months
|
Change from baseline in quality of life at 6 months
Time Frame: at baseline and 6 months
|
EuroQOL health questionnaire will be used.
|
at baseline and 6 months
|
Change from baseline in daytime sleepiness at 6 months
Time Frame: at baseline and 6 months
|
Epworth sleepiness scale will be used.
|
at baseline and 6 months
|
Abandons at 6 months
Time Frame: 6 months
|
Number of patients lost at follow up at 6 months of CPAP therapy.
|
6 months
|
Cost effectiveness at 6 months
Time Frame: 6 months
|
Costs in each group (telemedicine cost, CPAP carrying charge, number of visits and calls) will be compared.
|
6 months
|
Changes in treatment side effects
Time Frame: 6 months
|
6 months
|
|
Change in blood pressure at 6 months
Time Frame: at baseline and 6 months
|
at baseline and 6 months
|
|
Change in body mass index (in kg/m^2) at 6 months
Time Frame: at baseline and 6 months
|
at baseline and 6 months
|
|
Change from baseline in Visual analogue scale for quality of life at 6 months
Time Frame: at baseline and 6 months
|
Visual analogue scale for quality of life will be used
|
at baseline and 6 months
|
Change in weight (in kg) at 6 months
Time Frame: at baseline and 6 months
|
at baseline and 6 months
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Turino C, Benitez ID, Rafael-Palou X, Mayoral A, Lopera A, Pascual L, Vaca R, Cortijo A, Moncusi-Moix A, Dalmases M, Vargiu E, Blanco J, Barbe F, de Batlle J. Management and Treatment of Patients With Obstructive Sleep Apnea Using an Intelligent Monitoring System Based on Machine Learning Aiming to Improve Continuous Positive Airway Pressure Treatment Compliance: Randomized Controlled Trial. J Med Internet Res. 2021 Oct 18;23(10):e24072. doi: 10.2196/24072.
- Rafael-Palou X, Turino C, Steblin A, Sanchez-de-la-Torre M, Barbe F, Vargiu E. Comparative analysis of predictive methods for early assessment of compliance with continuous positive airway pressure therapy. BMC Med Inform Decis Mak. 2018 Sep 18;18(1):81. doi: 10.1186/s12911-018-0657-z.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SEPAR 2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea Syndrome
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
University Hospital, MontpellierCompletedComplex Sleep Apnea Syndrome | Chronic Heart Failure and | Obstructive Sleep Apnea Syndrome and | Idiopathic Central Sleep Apnea Syndrome | Idiopathic Induced Periodic Breathing | Central Sleep Apnea SyndromeFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingModerate Obstructive Sleep Apnea SyndromeFrance
-
Karolinska University HospitalCompletedObstructive Sleep Apnea Syndrome in ChildrenSweden
-
University of Alabama at BirminghamTerminatedObstructive Sleep Apnea Hypopnea Syndrome (OSAHS)United States
-
Sakarya UniversityUnknown
-
Sleepinnov TechnologyUniversity Hospital, Grenoble; ICUREsearchCompletedObstructive Sleep Apnea SyndromeFrance
-
LivaNovaNational Research Agency, FranceCompletedObstructive Sleep Apnea SyndromeFrance
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
Centre Hospitalier de ValenceCompletedObstructive Sleep Apnea/Hypopnea SyndromeFrance
Clinical Trials on CPAP + Standard care
-
Queen's UniversityTerminatedObstructive Sleep Apnea (OSA)Canada
-
Uppsala UniversityCompleted
-
Adelaide Institute for Sleep HealthNational Health and Medical Research Council, Australia; ResMed; Fisher and Paykel... and other collaboratorsUnknownCardiovascular Disease | Sleep ApneaAustralia, Brazil, China, India, Spain
-
New York UniversityAliko Dangote Foundation; Nigerian Institute of Medical Research; CDC FoundationRecruitingSARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory InfectionNigeria
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); Indiana UniversityCompletedStroke | Transient Ischemic AttackUnited States
-
University Hospital, ToulouseCompleted
-
Hospital Clinic of BarcelonaCompletedObstructive Sleep Apnea SyndromeSpain
-
Hospital Clinic of BarcelonaCompleted
-
University of Maryland, BaltimoreCenter for Vaccine Development - MaliTerminated
-
Rutgers, The State University of New JerseyNYU Langone HealthCompleted